GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Monopril

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Monopril and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02817360

    NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

    Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
    Type 2 diabetes Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00051389

    ACE Inhibition and Novel Cardiovascular Risk Factors

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2007-01
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00315016

    Eplerenone, ACE Inhibition and Albuminuria

    Not yet reported Radboud University Medical Center 30 participants Est. completion 2011-07 2 sites
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT00565396

    Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

    Not yet reported Shanghai Municipal Health Bureau 400 participants Est. completion 2008-07 26 sites
    Other conditions: Chronic Kidney Insufficiency, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Type 1 Receptor Blockers, Proteinuria
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00776334

    Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00776672

    Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 24 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00777972

    Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 34 participants Est. completion 2003-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00778713

    Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 33 participants Est. completion 2003-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01014338

    Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Imperial College London 80 participants Est. completion 2012-09 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01342614

    The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension

    Not yet reported China-Japan Friendship Hospital 140 participants Est. completion 2009-08
    Other conditions: Diabetes Mellitus, Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01867047

    ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

    Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone
    Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
    View official trial listing →
  • Status unknown NCT NCT02646397

    Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension

    Not yet reported Shanghai Changzheng Hospital 508 participants Est. completion 2017-12 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT03073018

    Prevention of Renal and Vascular Endstage Disease Intervention Trial

    Not yet reported University Medical Center Groningen 864 participants Est. completion 2003-11 Stand-alone
    Cardiovascular disease Other conditions: Microalbuminuria, Renal Disease
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Monopril, Fosinopril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.